跳至主要内容
临床试验/CTIS2024-512491-35-00
CTIS2024-512491-35-00招募中1 期

Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI

Aarhus Universitet0 个研究点目标入组 30 人开始时间: 2024年5月29日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Aged 18 – 85 years (all participants), Pre-menopausal women must be confirmed non-pregnant by an onsite test. (All female participants), Autosomal dominant polycystic kidney disease. (PKD group), CKD for any reason except PKD. (CKD group), Recent biopsy (within 3 months of MRI). (CKD group)

排除标准

  • Contraindications for MRI with contrast: - eGFR less than 30 ml/min/1.73m2 - Significant cardiac disease such as severe left ventricular outflow obstruction - Significant obstructive lung disease or severe asthma - Pacemaker, neurostimulator or cholera implant - Metal foreign bodies such as fragments and irremovable piercings - Unsafe medical implants (safety of heart valves, hips and the like must be confirmed) - Claustrophobia - Largest circumference including arms > 160 cm, Competing renal or systemic disease (except unspecific renal MRI findings, hypertension, atherosclerosis, well-regulated diabetes and hyperlipidemia/cholesterolemia which are allowed), Renovascular disease, Allergy to pyruvate

研究者

相似试验